Real-time enrollment status for this idh-mutant glioma clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 12:06 PM UTC
| NCT Number | NCT06478212 |
| Recruiting Status | Active, Not Recruiting |
| Condition | IDH-mutant glioma |
| Phase | Clinical Trial |
| Target Enrollment | 42 participants |
| Active Locations | 8 sites in the US |
| Sponsor | Institut de Recherches Internationales Servier |
| Last Updated on CT.gov | January 8, 2026 (Jan 8, 2026) |
As of March 2, 2026: Clinical trial NCT06478212 is currently active_not_recruiting participants. This clinical trial study for idh-mutant glioma is not currently accepting new participants at 8 locations across the United States. The study is sponsored by Institut de Recherches Internationales Servier. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06478212 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 8 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06478212 was last updated Jan 8, 2026 (January 8, 2026). HelloStudys verifies this status automatically.